Gemcitabine Hydrochloride → Gemcitabine

HRID 493017

반응식

HRID 493017 반응식
[CH:1]1[C:7]([NH2:8])=[N:6][C:4](=[O:5])[N:3]([C@@H:9]2[O:13][C@H:12]([CH2:14][OH:15])[C@@H:11]([OH:16])[C:10]2([F:18])[F:17])[CH:2]=1.Cl.OP([O-])(O)=O.OP([O-])([O-])=O.[Na+].[Na+].[Na+].[Cl-].[Cl-].[K+].[K+]>>[CH:1]1[C:7]([NH2:8])=[N:6][C:4](=[O:5])[N:3]([C@@H:9]2[O:13][C@H:12]([CH2:14][OH:15])[C@@H:11]([OH:16])[C:10]2([F:17])[F:18])[CH:2]=1

참가 물질

3

반응물 2

HCID 60749Gemcitabine HydrochlorideHCID 24978514Phosphate Buffered Saline

생성물 1

HCID 60750Gemcitabine

실험 절차

Reconstituted 200 mg of Gemcitabine HCl powder with 6.66 ml of PBS (phosphate buffered saline) to final concentration of 30 mg/ml.

출처 및 근거

ORD 기록
ord-0731a3325bb94b238b6e037d6c16449c
출처 데이터셋
uspto-grants-2009_05
특허 번호
US07534455B2

연결된 노트

불러오는 중…